Universal health care: failure of user fees leaves financing gap Comment 23 January 2013 Pages: 1 - 1
The US National Comprehensive Cancer Network (NCCN) has added everolimus [Afinitor] as a recommended treatment for renal cell carcinoma Media release 23 January 2013 Pages: 2 - 2
Nonadherence to antiepileptics increases healthcare use, costs Clinical study 23 January 2013 Pages: 3 - 3
The GRACE* intervention is cost neutral and may be cost saving in those at high risk of hospitalisation Clinical study 23 January 2013 Pages: 3 - 3
A new guideline to improve the diagnosis and management of chronic open angle glaucoma and ocular hypertension in the UK will be available from April 22 Media release 23 January 2013 Pages: 3 - 3
Oseltamivir a winner in fight against influenza virus infections News item 23 January 2013 Pages: 4 - 4
Assay-assisted chemotherapy may reduce ovarian cancer costs Clinical study 23 January 2013 Pages: 4 - 4
Secondary stroke prevention less common in older patients Clinical study 23 January 2013 Pages: 5 - 5
ADEs, potential ADEs in young inpatients common and costly Clinical study 23 January 2013 Pages: 6 - 6
As time has passed, more people appear to have had periods of not having health insurance in the US, but the periods are shorter Non-clinical study 23 January 2013 Pages: 6 - 6
Surgical strategies for BPH in the UK: an economic analysis Clinical study 23 January 2013 Pages: 7 - 7
Antihistamines in urticaria: better QOL, but prescribing issues News item 23 January 2013 Pages: 8 - 8
Altering therapy for patients with insomnia appears to be associated with increased direct medical costs Clinical study 23 January 2013 Pages: 8 - 8
A capecitabine plus oxaliplatin regimen [XELOX] is less costly than a fluorouracil, folinic acid and oxaliplatin regimen [FOLFOX6] Clinical study 23 January 2013 Pages: 8 - 8
Preliminary results from a new CIGNA study show a potential association between untreated periodontal disorders and increased medical costs Media release 23 January 2013 Pages: 8 - 8
Samarium-153-SM-lexidronam improves QOL in patients with prostate cancer Clinical study 23 January 2013 Pages: 10 - 10
The value of the global pharmaceutical market is predicted to grow by only 2.5%-3.5% on a constant dollar basis in 2009 Media release 23 January 2013 Pages: 10 - 10
The UK government is donating £40 million to a new global effort News item 23 January 2013 Pages: 11 - 11
The 2008 reforms to the Australian Pharmaceutical Benefits Scheme (PBS) are predicted to save $A7.4 billion over 10 years Media release 23 January 2013 Pages: 11 - 11
PHARMAC, New Zealand's drug funding agency, has approved funding Media release 23 January 2013 Pages: 11 - 11